Luminal diameter ratio of Vieussens' arterial ring is valuable in determining appropriate clinical management for patients with pathologic Vieussens' arterial ring.

BACKGROUND: Although the adverse events of pathologic Vieussens' arterial ring (VAR) have been reported, it is difficult to determine optimal clinical management. Thus, we hypothesized that the luminal diameter ratio of VAR obtained from coronary computed tomography angiography (CCTA) could be used as a clinical tool to inform appropriate patient management.

METHOD: A total of 29 patients with pathologic VAR were retrospectively recruited for this study. The VAR luminal diameter ratio was defined as a quotient of VAR fistula divided by the orifice of RCA or LAD, based on which, patients were divided into small fistula group and large fistula group. The AUC, sensitivity, specificity, positive and negative predictive values were obtained from ROC curve. The cutoff value of the VAR luminal diameter ratio was calculated and assessed during the follow-up.

RESULTS: The VAR luminal diameter ratio of fistula/RCA orifice was 0.505 ± 0.098 in small fistula group and 1.020 ± 0.150 in large fistula group. The VAR luminal diameter ratio of fistula/LAD orifice was 0.507 ± 0.123 in small fistula group and 1.039 ± 0.151 in large group. The value was correlated with the choice of the treatment (r = 0.643 p < 0.01, r = 0.627 p < 0.01). The AUC, sensitivity, specificity, positive and negative predictive values were 0.803, 54.5%, 100%, 100% and 78.3% of the fistula/RCA orifice ratio and 0.833, 63.64%, 94.44%, 87.5% and 81.0% of the fistula/LAD orifice ratio, respectively. The cutoff values of both fistula/RCA orifice and fistula/LAD orifice ratios were 0.676.

CONCLUSIONS: The VAR luminal diameter ratio may be a valuable index to determine appropriate treatment for patients with pathologic VAR.